By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...
Late in the third quarter, blood visibly dripped from the jersey of Central Catholic senior Aniela Kwo, who needed to change ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California’s low-cost insulin plan is more than a year behind schedule with no clear timeline. Advocates say the delay is ...
Some local governments across the state of West Virginia are cracking down on the regulations around beekeeping. Across the ...
A number of sessions on the second day of IPWatchdog LIVE examined the state of U.S. IP policy and the potential for change ...
Pope Francis was up and receiving therapy on Monday after apparently overcoming a setback in his recovery from pneumonia. The ...
A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the obesity treatment market.
Cedar Rapids Xavier girls basketball has leaned heavily on one of the state's top players this year and will look to do so ...
The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback